Both in Pharmaceuticals
Processa Pharmaceuticals vs Xenetic Biosciences
Over the past year PCSA returned −64.7% and XBIO returned −30.2%; their daily moves had a correlation of 0.20.
PCSA −64.7% XBIO −30.2%Growth of $1, one year, split-adjusted
| Metric | PCSA | XBIO |
|---|---|---|
| Price | $1.76 | $2.26 |
| Market cap | $4.9M | $5.3M |
| Today | −4.35% | −3.00% |
| 1 month | −14.6% | −43.2% |
| 6 months | −35.3% | −15.4% |
| Year to date | −38.9% | +4.1% |
| 1 year | −66.9% | −27.1% |
| Revenue growth (YoY) | — | +12.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −140.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.6× |
| Net cash | $196.3K | $6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 125.0% | 157.1% |
| Short % of float | 0.6% | 1.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).